The Philadelphia Inquirer takes a look at John Maris' work at the Children's Hospital of Philadelphia into neuroblastoma, an often fatal tumor affecting children. Within a little more than a year, Maris and his colleagues identified three genes associated with risk of neuroblastoma through a genome-wide association study and began a related drug trial as one of the genes identified is also implicated in some lung cancers.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.